Longitudinal SARS-CoV-2 Testing among the Unvaccinated Is Punctuated by Intermittent Positivity and Variable Rates of Increasing Cycle Threshold Values Article Swipe
Shawn E. Hawken
,
Subhashini A. Sellers
,
Jason R. Smedberg
,
Jeremy D. Ward
,
Avian Elliott
,
Herbert C. Whinna
,
William A. Fischer
,
Melissa B. Miller
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.17615/f2gf-sh15
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.17615/f2gf-sh15
The coronavirus disease 2019 (COVID-19) pandemic is complicated by cases of vaccine breakthrough and reinfection and widespread transmission of variants of concern (VOCs). Consequently, the need to interpret longitudinal positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests is crucial in guiding clinical decisions regarding infection control precautions and treatment. Although diagnostic real-time reverse transcription (RT)-PCR tests yield CT values that are inversely correlated with RNA quantity, these tests are only approved for qualitative interpretation. In this study, we performed a retrospective review of 72,217 SARS-CoV-2 positive tests and identified 264 patients with longitudinal positivity prior to vaccination and VOC circulation. Patients with longitudinal positivity fell into two categories: short-term (207, 78%) or prolonged (57, 22%) positivity, defined as ≤28 (range, 1 to 28; median, 16) days and >28 (range, 29 to 152; median, 41) days, respectively. In general, CT values increased over time in both groups; however, 11 short-term-positive patients had greater amounts of RNA detected at their terminal test than at the first positive test, and 6 patients had RNA detected at CT values of CT values as a proxy for infectivity, a predictor of severity, or a guide for patient care decisions in the absence of additional clinical context, particularly among the unvaccinated population. IMPORTANCE We describe the duration of positivity and the COVID-19 treatment and outcome characteristics of an unvaccinated population of patients with prolonged SARS-CoV-2 positivity. This investigation serves to highlight challenges in using CT values to guide clinical decisions among unvaccinated individuals.
Related Topics
Concepts
No concepts available.
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.17615/f2gf-sh15
- OA Status
- green
- OpenAlex ID
- https://openalex.org/W4414430084
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4414430084Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.17615/f2gf-sh15Digital Object Identifier
- Title
-
Longitudinal SARS-CoV-2 Testing among the Unvaccinated Is Punctuated by Intermittent Positivity and Variable Rates of Increasing Cycle Threshold ValuesWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-05-03Full publication date if available
- Authors
-
Shawn E. Hawken, Subhashini A. Sellers, Jason R. Smedberg, Jeremy D. Ward, Avian Elliott, Herbert C. Whinna, William A. Fischer, Melissa B. MillerList of authors in order
- Landing page
-
https://doi.org/10.17615/f2gf-sh15Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.17615/f2gf-sh15Direct OA link when available
- Cited by
-
0Total citation count in OpenAlex
Full payload
| id | https://openalex.org/W4414430084 |
|---|---|
| doi | https://doi.org/10.17615/f2gf-sh15 |
| ids.doi | https://doi.org/10.17615/f2gf-sh15 |
| ids.openalex | https://openalex.org/W4414430084 |
| fwci | 0.0 |
| type | article |
| title | Longitudinal SARS-CoV-2 Testing among the Unvaccinated Is Punctuated by Intermittent Positivity and Variable Rates of Increasing Cycle Threshold Values |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11754 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9829999804496765 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | SARS-CoV-2 detection and testing |
| topics[1].id | https://openalex.org/T12274 |
| topics[1].field.id | https://openalex.org/fields/16 |
| topics[1].field.display_name | Chemistry |
| topics[1].score | 0.9158999919891357 |
| topics[1].domain.id | https://openalex.org/domains/3 |
| topics[1].domain.display_name | Physical Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1606 |
| topics[1].subfield.display_name | Physical and Theoretical Chemistry |
| topics[1].display_name | Electrostatics and Colloid Interactions |
| topics[2].id | https://openalex.org/T11607 |
| topics[2].field.id | https://openalex.org/fields/22 |
| topics[2].field.display_name | Engineering |
| topics[2].score | 0.9002000093460083 |
| topics[2].domain.id | https://openalex.org/domains/3 |
| topics[2].domain.display_name | Physical Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2208 |
| topics[2].subfield.display_name | Electrical and Electronic Engineering |
| topics[2].display_name | Microwave and Dielectric Measurement Techniques |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| language | en |
| locations[0].id | doi:10.17615/f2gf-sh15 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S7407051488 |
| locations[0].source.type | repository |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | UNC Libraries |
| locations[0].source.host_organization | |
| locations[0].source.host_organization_name | |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | |
| locations[0].raw_type | article-journal |
| locations[0].license_id | |
| locations[0].is_accepted | False |
| locations[0].is_published | |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.17615/f2gf-sh15 |
| indexed_in | datacite |
| authorships[0].author.id | https://openalex.org/A5081196210 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-3274-9230 |
| authorships[0].author.display_name | Shawn E. Hawken |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Hawken, Shawn E. |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5054823570 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-2852-4634 |
| authorships[1].author.display_name | Subhashini A. Sellers |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Sellers, Subhashini A. |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5019855666 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Jason R. Smedberg |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Smedberg, Jason R. |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5061283252 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-0410-8559 |
| authorships[3].author.display_name | Jeremy D. Ward |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Ward, Jeremy D. |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5007374784 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Avian Elliott |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Elliott, Avian M. |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5055212805 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Herbert C. Whinna |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Whinna, Herbert C. |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5002687453 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-4900-098X |
| authorships[6].author.display_name | William A. Fischer |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Fischer, William A. |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5041028634 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-0296-3535 |
| authorships[7].author.display_name | Melissa B. Miller |
| authorships[7].author_position | last |
| authorships[7].raw_author_name | Miller, Melissa B. |
| authorships[7].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.17615/f2gf-sh15 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Longitudinal SARS-CoV-2 Testing among the Unvaccinated Is Punctuated by Intermittent Positivity and Variable Rates of Increasing Cycle Threshold Values |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T06:51:31.235846 |
| primary_topic.id | https://openalex.org/T11754 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9829999804496765 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | SARS-CoV-2 detection and testing |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.17615/f2gf-sh15 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S7407051488 |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | UNC Libraries |
| best_oa_location.source.host_organization | |
| best_oa_location.source.host_organization_name | |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | |
| best_oa_location.raw_type | article-journal |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.17615/f2gf-sh15 |
| primary_location.id | doi:10.17615/f2gf-sh15 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S7407051488 |
| primary_location.source.type | repository |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | UNC Libraries |
| primary_location.source.host_organization | |
| primary_location.source.host_organization_name | |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | |
| primary_location.raw_type | article-journal |
| primary_location.license_id | |
| primary_location.is_accepted | False |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.17615/f2gf-sh15 |
| publication_date | 2025-05-03 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index.1 | 121 |
| abstract_inverted_index.2 | 35 |
| abstract_inverted_index.6 | 168 |
| abstract_inverted_index.a | 80, 240, 244, 249 |
| abstract_inverted_index.11 | 148 |
| abstract_inverted_index.29 | 130 |
| abstract_inverted_index.In | 75, 137 |
| abstract_inverted_index.We | 268 |
| abstract_inverted_index.an | 282 |
| abstract_inverted_index.as | 118, 239 |
| abstract_inverted_index.at | 157, 162, 173, 178 |
| abstract_inverted_index.be | 233 |
| abstract_inverted_index.by | 8 |
| abstract_inverted_index.in | 40, 144, 190, 201, 255, 297 |
| abstract_inverted_index.is | 6, 38 |
| abstract_inverted_index.of | 10, 18, 20, 83, 154, 176, 246, 258, 272, 281, 285 |
| abstract_inverted_index.or | 112, 223, 248 |
| abstract_inverted_index.to | 26, 96, 122, 131, 220, 294, 301 |
| abstract_inverted_index.we | 78 |
| abstract_inverted_index.16) | 125 |
| abstract_inverted_index.264 | 90 |
| abstract_inverted_index.28; | 123 |
| abstract_inverted_index.41) | 134 |
| abstract_inverted_index.RNA | 65, 155, 171 |
| abstract_inverted_index.The | 0 |
| abstract_inverted_index.VOC | 99 |
| abstract_inverted_index.and | 13, 15, 48, 88, 98, 127, 167, 186, 217, 274, 278 |
| abstract_inverted_index.are | 61, 69 |
| abstract_inverted_index.but | 212 |
| abstract_inverted_index.for | 72, 242, 251 |
| abstract_inverted_index.had | 151, 170, 208 |
| abstract_inverted_index.ill | 216 |
| abstract_inverted_index.the | 24, 163, 256, 264, 270, 275 |
| abstract_inverted_index.two | 107 |
| abstract_inverted_index.was | 195 |
| abstract_inverted_index.(57, | 114 |
| abstract_inverted_index.152; | 132 |
| abstract_inverted_index.2019 | 3 |
| abstract_inverted_index.22%) | 115 |
| abstract_inverted_index.78%) | 111 |
| abstract_inverted_index.This | 291 |
| abstract_inverted_index.both | 145, 191 |
| abstract_inverted_index.care | 222, 253 |
| abstract_inverted_index.days | 126 |
| abstract_inverted_index.fell | 105 |
| abstract_inverted_index.into | 106 |
| abstract_inverted_index.more | 199 |
| abstract_inverted_index.must | 232 |
| abstract_inverted_index.need | 25 |
| abstract_inverted_index.only | 70 |
| abstract_inverted_index.over | 142 |
| abstract_inverted_index.seen | 196 |
| abstract_inverted_index.test | 160 |
| abstract_inverted_index.than | 161 |
| abstract_inverted_index.that | 60, 230 |
| abstract_inverted_index.this | 76, 227 |
| abstract_inverted_index.time | 143 |
| abstract_inverted_index.were | 213, 218 |
| abstract_inverted_index.when | 235 |
| abstract_inverted_index.with | 64, 92, 102, 205, 287 |
| abstract_inverted_index.(207, | 110 |
| abstract_inverted_index.acute | 31 |
| abstract_inverted_index.after | 181 |
| abstract_inverted_index.among | 263, 305 |
| abstract_inverted_index.cases | 9 |
| abstract_inverted_index.days, | 135 |
| abstract_inverted_index.first | 164 |
| abstract_inverted_index.guide | 250, 302 |
| abstract_inverted_index.least | 179 |
| abstract_inverted_index.often | 214 |
| abstract_inverted_index.prior | 95 |
| abstract_inverted_index.proxy | 241 |
| abstract_inverted_index.study | 228 |
| abstract_inverted_index.test, | 166 |
| abstract_inverted_index.tests | 37, 56, 68, 87 |
| abstract_inverted_index.their | 158 |
| abstract_inverted_index.these | 67 |
| abstract_inverted_index.three | 197 |
| abstract_inverted_index.times | 198 |
| abstract_inverted_index.using | 298 |
| abstract_inverted_index.yield | 57 |
| abstract_inverted_index.>28 | 128 |
| abstract_inverted_index.≤28 | 119 |
| abstract_inverted_index.<35 | 177 |
| abstract_inverted_index.(22%). | 225 |
| abstract_inverted_index.72,217 | 84 |
| abstract_inverted_index.review | 82 |
| abstract_inverted_index.serves | 293 |
| abstract_inverted_index.severe | 30 |
| abstract_inverted_index.study, | 77 |
| abstract_inverted_index.values | 59, 140, 175, 238, 300 |
| abstract_inverted_index.(VOCs). | 22 |
| abstract_inverted_index.(range, | 120, 129 |
| abstract_inverted_index.absence | 257 |
| abstract_inverted_index.amounts | 153 |
| abstract_inverted_index.caution | 231 |
| abstract_inverted_index.concern | 21 |
| abstract_inverted_index.control | 46 |
| abstract_inverted_index.crucial | 39 |
| abstract_inverted_index.defined | 117 |
| abstract_inverted_index.disease | 2 |
| abstract_inverted_index.diverse | 209 |
| abstract_inverted_index.greater | 152 |
| abstract_inverted_index.groups, | 192 |
| abstract_inverted_index.groups; | 146 |
| abstract_inverted_index.guiding | 41 |
| abstract_inverted_index.initial | 182 |
| abstract_inverted_index.median, | 124, 133 |
| abstract_inverted_index.outcome | 279 |
| abstract_inverted_index.patient | 252 |
| abstract_inverted_index.results | 188 |
| abstract_inverted_index.reverse | 53 |
| abstract_inverted_index.vaccine | 11 |
| abstract_inverted_index.(RT)-PCR | 55 |
| abstract_inverted_index.Although | 50 |
| abstract_inverted_index.COVID-19 | 276 |
| abstract_inverted_index.Overall, | 226 |
| abstract_inverted_index.Patients | 101, 204 |
| abstract_inverted_index.although | 193 |
| abstract_inverted_index.approved | 71 |
| abstract_inverted_index.clinical | 42, 210, 260, 303 |
| abstract_inverted_index.context, | 261 |
| abstract_inverted_index.deceased | 224 |
| abstract_inverted_index.describe | 269 |
| abstract_inverted_index.detected | 156, 172 |
| abstract_inverted_index.duration | 271 |
| abstract_inverted_index.general, | 138 |
| abstract_inverted_index.however, | 147 |
| abstract_inverted_index.negative | 187 |
| abstract_inverted_index.occurred | 189 |
| abstract_inverted_index.pandemic | 5 |
| abstract_inverted_index.patients | 91, 150, 169, 286 |
| abstract_inverted_index.positive | 29, 86, 165, 185 |
| abstract_inverted_index.syndrome | 33 |
| abstract_inverted_index.terminal | 159 |
| abstract_inverted_index.variants | 19 |
| abstract_inverted_index.decisions | 43, 254, 304 |
| abstract_inverted_index.highlight | 295 |
| abstract_inverted_index.increased | 141 |
| abstract_inverted_index.infection | 45 |
| abstract_inverted_index.interpret | 27 |
| abstract_inverted_index.inversely | 62 |
| abstract_inverted_index.patients. | 203 |
| abstract_inverted_index.performed | 79 |
| abstract_inverted_index.predictor | 245 |
| abstract_inverted_index.prolonged | 113, 206, 288 |
| abstract_inverted_index.quantity, | 66 |
| abstract_inverted_index.real-time | 52 |
| abstract_inverted_index.regarding | 44 |
| abstract_inverted_index.severity, | 247 |
| abstract_inverted_index.treatment | 277 |
| abstract_inverted_index.(COVID-19) | 4 |
| abstract_inverted_index.SARS-CoV-2 | 85, 289 |
| abstract_inverted_index.additional | 259 |
| abstract_inverted_index.challenges | 296 |
| abstract_inverted_index.correlated | 63 |
| abstract_inverted_index.critically | 215 |
| abstract_inverted_index.diagnostic | 51 |
| abstract_inverted_index.discharged | 219 |
| abstract_inverted_index.emphasized | 234 |
| abstract_inverted_index.frequently | 200 |
| abstract_inverted_index.high-level | 221 |
| abstract_inverted_index.identified | 89 |
| abstract_inverted_index.infection. | 183 |
| abstract_inverted_index.population | 284 |
| abstract_inverted_index.positivity | 94, 104, 207, 273 |
| abstract_inverted_index.short-term | 109 |
| abstract_inverted_index.treatment. | 49 |
| abstract_inverted_index.widespread | 16 |
| abstract_inverted_index.Oscillating | 184 |
| abstract_inverted_index.categories: | 108 |
| abstract_inverted_index.complicated | 7 |
| abstract_inverted_index.coronavirus | 1, 34 |
| abstract_inverted_index.oscillation | 194 |
| abstract_inverted_index.population. | 266 |
| abstract_inverted_index.positivity, | 116 |
| abstract_inverted_index.positivity. | 290 |
| abstract_inverted_index.precautions | 47 |
| abstract_inverted_index.qualitative | 73 |
| abstract_inverted_index.reinfection | 14 |
| abstract_inverted_index.respiratory | 32 |
| abstract_inverted_index.vaccination | 97 |
| abstract_inverted_index.(SARS-CoV-2) | 36 |
| abstract_inverted_index.breakthrough | 12 |
| abstract_inverted_index.circulation. | 100 |
| abstract_inverted_index.demonstrates | 229 |
| abstract_inverted_index.individuals. | 307 |
| abstract_inverted_index.infectivity, | 243 |
| abstract_inverted_index.interpreting | 236 |
| abstract_inverted_index.longitudinal | 28, 93, 103 |
| abstract_inverted_index.particularly | 262 |
| abstract_inverted_index.transmission | 17 |
| abstract_inverted_index.unvaccinated | 265, 283, 306 |
| abstract_inverted_index.Consequently, | 23 |
| abstract_inverted_index.investigation | 292 |
| abstract_inverted_index.respectively. | 136 |
| abstract_inverted_index.retrospective | 81 |
| abstract_inverted_index.transcription | 54 |
| abstract_inverted_index.40 days | 180 |
| abstract_inverted_index.characteristics | 211, 280 |
| abstract_inverted_index.interpretation. | 74 |
| abstract_inverted_index.prolonged-positive | 202 |
| abstract_inverted_index.short-term-positive | 149 |
| abstract_inverted_index.<em>C<sub>T</sub></em> | 58, 139, 174, 237, 299 |
| abstract_inverted_index.<strong>IMPORTANCE</strong> | 267 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 8 |
| citation_normalized_percentile.value | 0.50358143 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |